Nyxoah S.A.
Clinical trials sponsored by Nyxoah S.A., explained in plain language.
Develops implantable neurostimulation devices for sleep apnea.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New implant zaps nerve to treat sleep apnea without CPAP Results expected Sep 2026 (estimated)
- New implant could help sleep apnea sufferers ditch CPAP Results expected Oct 2026 (estimated)
-
New implant could help sleep apnea sufferers ditch the CPAP mask
Disease control OngoingThis study tests a device that stimulates a nerve in the neck to keep the airway open during sleep. It is for adults with moderate to severe obstructive sleep apnea who cannot use a CPAP machine. The goal is to see if the device is safe and improves breathing and sleep quality.
Sponsor: Nyxoah S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New implant could help sleep apnea sufferers ditch CPAP
Disease control OngoingThis study follows 110 adults with moderate to severe obstructive sleep apnea who have the Genio® device implanted. The device stimulates a nerve to keep the airway open during sleep. Researchers will track safety and effectiveness over 5 years, including changes in breathing pau…
Sponsor: Nyxoah S.A. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New implant zaps nerve to treat sleep apnea without CPAP
Disease control OngoingThis study tests a device called the Genio® System, which is implanted under the chin and stimulates a nerve to keep the airway open during sleep. It is for people with obstructive sleep apnea who have not been helped by CPAP machines and have a specific type of airway collapse. …
Sponsor: Nyxoah S.A. • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC